Plenty of eastern promise for Irish pharma firms

Firms should prosper from the EU-Japan trade deal Japan may have the dubious distinction of being the least understood pharmaceutical market in the developed world, writes John Whelan.

But Irish suppliers to the market have managed to put aside any misunderstanding and push exports of healthcare products to new heights in the market this year.